Hypercalcemia of Down Syndrome

We present a case of hypercalcemia in a 12-month-old female with Down syndrome. The patient presented with significant weight loss (810 g since her 6-month visit) and severe growth failure (weight 5.8 kg, -4.5 SDs). Laboratory evaluation revealed severe hypercalcemia with appropriately suppressed PTH and 1,25-hydroxyvitamin D levels. Renal ultrasound confirmed medullary nephrocalcinosis. After excluding common etiologies, the patient was diagnosed with hypercalcemia of Down syndrome, also termed Abnormal Calcium, Calcinosis, Creatinine in Down syndrome. Treatment with intravenous fluids, calcitonin, and transition to a low-calcium formula (Calcilo XD) normalized serum calcium levels. The patient maintained normal calcium levels on restricted dietary calcium intake for 7 months after discharge. This case adds to the limited literature on this rare but significant association, highlighting the importance of considering hypercalcemia in patients with Down syndrome presenting with growth failure. Although the pathophysiology remains unclear, a hyperabsorptive intestinal mechanism has been proposed. Early recognition and dietary calcium restriction are essential to prevent significant morbidity in affected children.

Authors

Institutions

Publication Details

Journal
JCEM Case Reports
Published
2025-09-23
DOI
https://doi.org/10.1210/jcemcr/luaf244
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypercalcemia of Down Syndrome

Melissa Kaori Silva Litao, Seth Lamb, Jacob M. Redel, Nasreen Talib
JCEM Case Reports
Parathyroid Disorders and Treatments
article

Hypercalcemia of Down Syndrome

Melissa Kaori Silva Litao, Seth Lamb, Jacob M. Redel, Nasreen Talib
article en

Abstract

We present a case of hypercalcemia in a 12-month-old female with Down syndrome. The patient presented with significant weight loss (810 g since her 6-month visit) and severe growth failure (weight 5.8 kg, -4.5 SDs). Laboratory evaluation revealed severe hypercalcemia with appropriately suppressed PTH and 1,25-hydroxyvitamin D levels. Renal ultrasound confirmed medullary nephrocalcinosis. After excluding common etiologies, the patient was diagnosed with hypercalcemia of Down syndrome, also termed Abnormal Calcium, Calcinosis, Creatinine in Down syndrome. Treatment with intravenous fluids, calcitonin, and transition to a low-calcium formula (Calcilo XD) normalized serum calcium levels. The patient maintained normal calcium levels on restricted dietary calcium intake for 7 months after discharge. This case adds to the limited literature on this rare but significant association, highlighting the importance of considering hypercalcemia in patients with Down syndrome presenting with growth failure. Although the pathophysiology remains unclear, a hyperabsorptive intestinal mechanism has been proposed. Early recognition and dietary calcium restriction are essential to prevent significant morbidity in affected children.

JCEM Case ReportsVol. 3(12)
Children's Mercy Hospital (US), Mercy Hospital (US)
Openalex Percentile: Top 63%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hypercalcemia of Down Syndrome — Melissa Kaori Silva Litao, Seth Lamb, et al. · JCEM Case Reports (2025) | TGRS Research Map | TGRS